Clinical Trials in Illinois

Showing 13661-13680 of 19,692 trials

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

NCT01484028

This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.

Johnson & Johnson Vision Care, Inc.275 participantsStarted Nov 2011

Mission Viejo, California, United States • Mission Viejo, California, United States • Pismo Beach, California, United States +12 more locations

COMPLETEDPhase 340 miles

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

NCT02517021

NEPA-15-18 is a clinical study assessing safety of pro-netupitant and palonosetron, two antiemetic drugs, given with oral dexamethasone. The objective of the study is to evaluate if pro-netupitant and palonosetron are safe when administered to prevent nausea and vomiting after administration of repeated cycles of chemotherapy.

Chemotherapy-Induced Nausea and Vomiting

Helsinn Healthcare SA405 participantsStarted Nov 2015

Santa Monica, California, United States • Whittier, California, United States • Grand Junction, Colorado, United States +71 more locations

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Find Trials by Condition in Illinois

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Clinical Performance Comparison of Two Contact Lenses

Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL